Market Place
Sourcing Support
Abata Therapeutics Appoints Joanne Beck As CTO
16 Sep 2024 //
GLOBENEWSWIRE
Abata Therapeutics Gets FDA Fast Track For ABA-101 In Multiple Sclerosis
22 Aug 2024 //
GLOBENEWSWIRE
Abata Therapeutics Gets Bristol Myers Investment For Treg Cell Therapy
15 Aug 2024 //
GLOBENEWSWIRE
Abata Therapeutics` IND Cleared For ABA-101 In Multiple Sclerosis
09 Jul 2024 //
GLOBENEWSWIRE
Abata Therapeutics Announces Second Development Candidate, ABA-201
24 Aug 2023 //
BUSINESSWIRE
Abata Therapeutics to Present at Upcoming Investor and Industry Events in June
31 May 2023 //
BUSINESSWIRE
Abata Therapeutics Announces the Appointment of Leonard Dragone
20 Apr 2023 //
BUSINESSWIRE
Abata Therapeutics Appoints Ellen Cahir-McFarland, Ph.D., as CSO
07 Dec 2022 //
BUSINESSWIRE
Abata to Participate in Guggenheim’s 4th Annual Immunology and Neurology Day
09 Nov 2022 //
BUSINESSWIRE
Abata Therapeutics to Present at Upcoming Investor Conferences
02 Jun 2022 //
BUSINESSWIRE
Abata Announces Formation of Advisory Board; Has Leading Industry Experts
06 Apr 2022 //
BUSINESSWIRE
Abata Therapeutics Strengthens Board of Directors
29 Jul 2021 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.